Wang Jingwen, Dong Mohan, Lu Yang, Zhao Xian, Li Xin, Wen Aidong
Int J Clin Pharmacol Ther. 2015 Aug;53(8):605-15. doi: 10.5414/CP202334.
To assess the impact of pharmacist interventions on rational use of prophylactic antibiotics and cost saving in elective cesarean section and the economic outcomes of implementing pharmacist interventions.
A pre-to-post intervention design was applied to the practices of prophylactic antibiotic use in the department of gynecology and obstetrics in a Chinese tertiary hospital. Patients admitted during a 3-month period from June to August 2012 and during that from October to December 2012 undergoing elective cesarean section were assigned to the pre-intervention and the post-intervention group, respectively. Pharmacist interventions were performed in the post-intervention group, including obstetrician education, realtime monitoring of clinical records and making recommendations to obstetricians on prophylactic antibiotic prescription based on the criteria set at the beginning of the study. Data from the two groups were then compared to evaluate the outcomes of pharmacist interventions. Cost-outcome analysis was performed to determine the economic effect of implementing pharmacist interventions in preoperative antibiotic prophylaxis.
Pharmacist interventions led to significant reductions in antibiotic usage cost/patient-day (p < 0.001), mean antibiotic cost (p < 0.001), mean total drug cost (p < 0.001), mean total hospitalization cost (p < 0.001), the duration of prophylaxis antibiotics (p < 0.001) and a significant increase by 19.29% in the percentage of cases adhering to all of the four criteria (p < 0.001). The ratio of the saving in antibiotic use to the cost of pharmacist time was 27.23 : 1 and the net cost benefit was $65,255.84.
This study provides evidence that pharmacist interventions promoted rational use of prophylactic antibiotics and substantial cost saving in elective cesarean section.
评估药剂师干预对择期剖宫产预防性抗生素合理使用及成本节约的影响,以及实施药剂师干预的经济效果。
采用干预前后设计,对中国一家三级医院妇产科预防性抗生素使用的实践进行研究。将2012年6月至8月以及2012年10月至12月这两个为期3个月的时间段内入院接受择期剖宫产的患者分别分配至干预前组和干预后组。在干预后组实施药剂师干预,包括对产科医生进行教育、实时监测临床记录,并根据研究开始时设定的标准就预防性抗生素处方向产科医生提出建议。然后比较两组数据以评估药剂师干预的效果。进行成本效益分析以确定在术前抗生素预防中实施药剂师干预的经济效果。
药剂师干预使每位患者每天的抗生素使用成本(p < 0.001)、平均抗生素成本(p < 0.001)、平均总药物成本(p < 0.001)、平均总住院成本(p < 0.001)、预防性抗生素使用时长(p < 0.001)显著降低,并且符合所有四项标准的病例百分比显著提高了19.29%(p < 0.001)。抗生素使用节约成本与药剂师时间成本的比率为27.23 : 1,净成本效益为65,255.84美元。
本研究提供了证据表明药剂师干预促进了择期剖宫产预防性抗生素的合理使用并大幅节约了成本。